CARGO Act of 2025
- Sponsor
- Rep. Nehls, Troy E. [R-TX-22]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Feb 6, 2025
Bottom line
The CARGO Act of 2025 seeks to restrict all NIH funding for live animal research to domestic institutions only, citing concerns over animal welfare oversight and accountability for taxpayer dollars spent abroad.
What it actually does
This bill prohibits the National Institutes of Health (NIH) from providing any financial support, including grants or contracts, for research activities that use live animals unless that research is conducted within the United States or its territories. It aims to address concerns about the lack of NIH oversight and potential mistreatment of animals in foreign research projects funded by U.S. taxpayers.
Proponents argue
Proponents argue that this bill is essential to ensure that U.S. taxpayer money is not used to fund animal research in foreign countries where oversight is lacking and animal welfare standards may be lower than those in the United States. They contend that the current self-reporting system for foreign organizations creates a significant risk of misrepresentation and mistreatment, which this bill would eliminate by requiring all NIH-funded animal research to occur domestically under U.S. regulatory scrutiny.
Opponents contend
Opponents might argue that this measure could severely impede critical international scientific collaboration, limiting access to diverse research environments, unique animal models, and specialized expertise found abroad. They could contend that restricting funding geographically might slow down the pace of scientific discovery and hinder efforts to address global health challenges that require a worldwide research effort.
The bill is exceptionally short and clearly written, making it very accessible for a quick and thorough evaluation.
Section 3, amending Section 495 of the Public Health Service Act
Prohibition on NIH Support for Live Animal Research Outside the United States
This provision amends the Public Health Service Act to explicitly forbid the National Institutes of Health (NIH) from providing any form of financial support, including grants, contracts, cooperative agreements, or technical assistance, for research activities or programs that involve the use of live animals. This prohibition applies unless such research is conducted within the geographical boundaries of the United States, which includes the several States, the District of Columbia, and any territory or possession of the United States.
Supporters argue
Supporters argue this provision ensures greater accountability and ethical treatment of animals by limiting funding to facilities operating under U.S. regulatory oversight, which includes regular inspections and adherence to specific animal welfare standards. They highlight the findings that NIH does not inspect foreign organizations, creating a risk of misrepresentation and mistreatment that this provision directly addresses.
Critics contend
Critics might contend that this restriction could severely hamper international scientific collaboration, potentially delaying breakthroughs in areas where foreign researchers possess unique expertise, resources, or access to specific disease models. They may argue that it could force U.S. researchers to duplicate efforts or miss out on valuable data from global studies, ultimately hindering the pace of scientific advancement.
Tradeoffs
This provision navigates the tension between ensuring robust oversight and ethical treatment of research animals, particularly with taxpayer funds, and the potential benefits derived from international scientific collaboration, which can offer diverse research environments and specialized expertise.